by irenesoler | Mar 12, 2023 | Uncategorized
Baricitinib is the first JAK inhibitor approved in the US and Europe for the treatment of severe alopecia areata. In the UK the national institute for health and care excellence NICE evaluates new “technologies” for their efficacy and cost effectiveness...
by irenesoler | Dec 12, 2021 | Uncategorized
Research into JAK inhibitors as a treatment for alopecia areata continues and we have now seen the first peer reviewed publication of a placebo controlled trial for the drug Baricitinib, showing response rates of over 50% achieving an improvement to less than 20%...
by irenesoler | Mar 28, 2021 | Uncategorized
So far, 2021 has been really busy in the private sector for dermatology. There is no doubt this is in part due to Covid, with difficulty for patients getting to see their own doctor and longer than normal waits in the NHS. Locally in the NHS, the average wait for a...
by irenesoler | Jan 24, 2021 | Uncategorized
The past year has seen a shift in how patients access healthcare. With limited access to GPs and challenges in getting seen and referred to NHS specialist care, more patients are choosing to take matters into their own hands and self refer for private healthcare. But...
by irenesoler | Jan 16, 2021 | Uncategorized
This Thursday I will be starting the first of monthly education sessions aimed at GPs. This is following on from the successful Mole Hill series I ran during the first lock down last May. Instead of weekly sessions, we will be hosting these talks on a monthly basis...
by irenesoler | Dec 19, 2020 | Uncategorized
As we reach the end of the year it is a good time to look back and reflect on a year like no other. It’s hard to believe that twelve months ago none of us had heard of Covid, Zoom, social distancing and lockdowns. NHS services have had to radically change and...
